232 related articles for article (PubMed ID: 34929692)
1. Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
Jung J; Lee JH; Park YS
Nephron; 2022; 146(4):327-334. PubMed ID: 34929692
[TBL] [Abstract][Full Text] [Related]
2. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
3. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR; Franco MF; Kirsztajn GM
J Bras Nefrol; 2015; 37(4):475-80. PubMed ID: 26648497
[TBL] [Abstract][Full Text] [Related]
4. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics and long-term outcomes of steroid-resistant nephrotic syndrome in children: impact of initial kidney histology.
Watanabe Y; Fujinaga S; Endo A; Endo S; Nakagawa M; Sakuraya K
Pediatr Nephrol; 2020 Dec; 35(12):2377-2381. PubMed ID: 32964318
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
Meyrier A; Noël LH; Auriche P; Callard P
Kidney Int; 1994 May; 45(5):1446-56. PubMed ID: 8072258
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.
Tune BM; Mendoza SA
J Am Soc Nephrol; 1997 May; 8(5):824-32. PubMed ID: 9176855
[TBL] [Abstract][Full Text] [Related]
9. Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy.
Ramachandran R; Bharati J; Rao I; Kashif AW; Nada R; Minz R; Gupta KL; Kohli HS
Nephrology (Carlton); 2019 Dec; 24(12):1241-1247. PubMed ID: 30586217
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cyclophosphamide in steroid-sensitive childhood nephrotic syndrome with different morphological lesions.
Tejani A; Phadke K; Nicastri A; Adamson O; Chen CK; Trachtman H; Tejani C
Nephron; 1985; 41(2):170-3. PubMed ID: 4047274
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
Pelletier JH; Kumar KR; Engen R; Bensimhon A; Varner JD; Rheault MN; Srivastava T; Straatmann C; Silva C; Davis TK; Wenderfer SE; Gibson K; Selewski D; Barcia J; Weng P; Licht C; Jawa N; Kallash M; Foreman JW; Wigfall DR; Chua AN; Chambers E; Hornik CP; Brewer ED; Nagaraj SK; Greenbaum LA; Gbadegesin RA
Pediatr Nephrol; 2018 Oct; 33(10):1773-1780. PubMed ID: 29982878
[TBL] [Abstract][Full Text] [Related]
12. Synaptopodin immunoexpression in steroid-responsive and steroid-resistant minimal change disease and focal segmental glomerulosclerosis.
Wagrowska-Danilewicz M; Danilewicz M
Nefrologia; 2007; 27(6):710-5. PubMed ID: 18336100
[TBL] [Abstract][Full Text] [Related]
13. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
15. C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.
Kim K; Son HE; Ryu JY; Lee H; Han SH; Ryu DR; Paik JH; Kim S; Na KY; Chae DW; Chin HJ; Oh SW
PLoS One; 2019; 14(4):e0215217. PubMed ID: 31002691
[TBL] [Abstract][Full Text] [Related]
16. Childhood minimal change disease and focal segmental glomerulosclerosis: a continuous spectrum of disease? Pathologic study of 33 cases with long-term follow-up.
Lichtig C; Ben-Izhak O; On A; Levy J; Allon U
Am J Nephrol; 1991; 11(4):325-31. PubMed ID: 1799192
[TBL] [Abstract][Full Text] [Related]
17. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
18. Clinico-biochemical Profile of Biopsy-proven Minimal Change Disease in Adults from a Tertiary Care Center in South India.
Udupa KRN; Eshwarappa M; Gurudev KC; Gireesh MS; Reddy R; Yousuff M
Saudi J Kidney Dis Transpl; 2023 May; 34(3):242-249. PubMed ID: 38231719
[TBL] [Abstract][Full Text] [Related]
19. Do current recommendations for kidney biopsy in nephrotic syndrome need modifications?
Gulati S; Sharma AP; Sharma RK; Gupta A; Gupta RK
Pediatr Nephrol; 2002 Jun; 17(6):404-8. PubMed ID: 12107803
[TBL] [Abstract][Full Text] [Related]
20. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
